01 6GILEAD
02 90GILEAD SCIENCES INC
03 15JANSSEN PRODS
01 210039718*PED
02 27125879
03 27176220
04 27176220*PED
05 77390791
06 67390791*PED
07 27635704
08 27635704*PED
09 17700645
10 88148374
11 28148374*PED
12 18518987
13 58592397
14 28633219
15 28633219*PED
16 38716264
17 108754065
18 68754065*PED
19 18841310
20 28981103
21 28981103*PED
22 29216996
23 109296769
24 39457036
25 29708342
26 29732092
27 39744181
28 29891239
29 310039718
30 210385067
31 110548846
32 110786518
33 110857102
34 111744802
35 69296769*PED
36 29891239*PED
01 51Y
02 60Blank
01 76Y
02 35Blank
01 142024-01-13
02 12024-02-16
03 72025-04-17
04 22025-04-21
05 62025-10-17
06 12025-12-09
07 22026-08-27
08 42026-10-26
09 12026-12-26
10 22027-02-27
11 42027-04-26
12 102029-09-03
13 42030-03-03
14 22030-04-30
15 22030-10-30
16 202032-08-15
17 32032-10-06
18 12033-01-14
19 122033-02-15
20 22033-04-06
21 42033-12-19
22 42035-06-19
23 22036-11-08
24 12038-07-19
Patent Expiration Date : 2032-08-15
EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR ALAFENAMIDE FUMARATE
US Patent Number : 9296769
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 208351
Patent Use Code : U-257
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2032-08-15
Patent Expiration Date : 2030-04-30
COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
US Patent Number : 8633219
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 203100
Patent Use Code : U-257
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2030-04-30
Patent Expiration Date : 2024-01-13
EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE
US Patent Number : 8592397
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 202123
Patent Use Code : U-257
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2024-01-13
Patent Expiration Date : 2026-10-26
COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
US Patent Number : 7635704
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 203100
Patent Use Code : U-257
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2026-10-26
Patent Expiration Date : 2024-01-13
EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
US Patent Number : 8592397
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 21752
Patent Use Code : U-248
Delist Requested :
Patent Use Description : TREATMENT OF HIV
Patent Expiration Date : 2024-01-13
Patent Expiration Date : 2024-01-13
COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
US Patent Number : 8716264
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 203100
Patent Use Code : U-257
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2024-01-13
Patent Expiration Date : 2025-12-09
EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE
US Patent Number : 8841310
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 202123
Patent Use Code : U-257
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2025-12-09
Patent Expiration Date : 2029-09-03
COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US Patent Number : 8148374
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 207561
Patent Use Code : U-1279
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2029-09-03
Patent Expiration Date : 2032-08-15
COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US Patent Number : 8754065
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 207561
Patent Use Code : U-257
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2032-08-15
Patent Expiration Date : 2024-01-13
EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
US Patent Number : 9457036
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 21752
Patent Use Code : U-257
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2024-01-13
LOOKING FOR A SUPPLIER?
